Conclusions and research needs in knowledge networks and markets

This final chapter presents conclusions and policy recommendations. It identifies what are the common features of knowledge networks and markets (KNMs) and on what criteria they differ. It reiterates why KNMs matter for innovators in the biopharmaceutical sector, in particular because of their contribution to: addressing financial pressures, accelerating science and development, improving health outcomes, and improving the regulatory dialogue. The chapter concludes with a review of the support that KNMs currently enjoy from government and sets out proposals for possible future focus.